Covered recipient · General Payments record
JYOTI N MANEKAR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$7,100.34
- Reported across 405 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $553.29 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $377.69 | 14 |
| Lilly USA, LLC | $50.19 | 3 |
| Currax Pharmaceuticals LLC | $28.75 | 2 |
| Pacira Pharmaceuticals Incorporated | $22.54 | 1 |
| Abbott Laboratories | $22.16 | 1 |
| CONMED Corporation | $19.71 | 1 |
| Astellas Pharma US Inc | $16.55 | 1 |
| VIVUS LLC | $15.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.16 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125056426 | CMS |
| Astellas Pharma US Inc | $16.55 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139315562 | CMS |
| CONMED Corporation | $19.71 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142399583 | CMS |
| Currax Pharmaceuticals LLC | $14.63 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089512162 | CMS |
| Currax Pharmaceuticals LLC | $14.12 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089512164 | CMS |
| Lilly USA, LLC | $14.92 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135093537 | CMS |
| Lilly USA, LLC | $18.23 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135113442 | CMS |
| Lilly USA, LLC | $17.04 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135091957 | CMS |
| Novo Nordisk Inc | $17.88 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097071254 | CMS |
| Novo Nordisk Inc | $19.72 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097811835 | CMS |
| Novo Nordisk Inc | $19.42 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097102926 | CMS |
| Novo Nordisk Inc | $8.75 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097768651 | CMS |
| Novo Nordisk Inc | $19.60 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097414350 | CMS |
| Novo Nordisk Inc | $20.69 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097505190 | CMS |
| Novo Nordisk Inc | $19.02 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097309729 | CMS |
| Novo Nordisk Inc | $20.32 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096710218 | CMS |
| Novo Nordisk Inc | $22.38 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096836485 | CMS |
| Novo Nordisk Inc | $124.14 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096721374 | CMS |
| Novo Nordisk Inc | $24.93 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097749749 | CMS |
| Novo Nordisk Inc | $19.06 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097427054 | CMS |
| Novo Nordisk Inc | $17.60 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096817565 | CMS |
| Novo Nordisk Inc | $24.18 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097178714 | CMS |
| Pacira Pharmaceuticals Incorporated | $22.54 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151250549 | CMS |
| VIVUS LLC | $15.70 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129416912 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.